Table 2.
Fungi-derived compounds and their functions
Fungi-derived compounds | Functions | References | |
---|---|---|---|
Quorum-sensing molecules | Farnesol |
Filamentous growth and formation ↓ C. albicans biofilm formation ↓ |
[85–91] |
Drug-resistance ↓ Synergy with fluconazole, amphotericin B or micafungin, anti-fungal AMP peptidomimetics, chitosan (CS), and cysteine protease metacaspase | |||
Tyrosol | C. albicans biofilm formation ↓ | ||
Fungal secondary metabolites |
Source of antibiotics and immunosuppressant drugs Hepatotoxicity and/or nephrotoxicity |
[54, 92, 93] | |
Fungi-derived extractives | (1,3)/(1,6)-β-glucan | Obesity property ↓ | [94–97] |
Pyronepolyene C-glucoside iso-D8646-2-6 | Influenza A virus (H1N1) infection ↓ | ||
Xanthones | Virus infection (H1N1, simplex virus types 1 and 2) ↓ | ||
Some mangrove-associated or soil-associated fungus-derived compounds | Virus infection ↓ | ||
Other compounds | Candidalysin |
Systematic infection ↑ Phagocytic clearance ↓ Severity of ethanol-associated hepatitis ↑ |
[98–110] |
Prostaglandins E2 (PGE2) |
Biofilm formation ↑ Yeast to hyphae transition ↑ C. albicans clearance by phagocytes ↓ |
||
Oxylipins | Modulating immune responses |
“↑” indicates increase and “↓” indicates decrease